Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard M Neve

Showing results (21-30 of 46) with videos related to

Pageof 5
Sort By:
Nature|May 20, 2016
Reproducible pharmacogenomic profiling of cancer cell line panelsPeter M Haverty, Eva Lin, Jenille Tan, et al.
Journal of Mammary Gland Biology and Neoplasia|June 4, 2010
Epithelial mesenchymal transition traits in human breast cancer cell lines parallel the CD44(hi/)CD24 (lo/-) stem cell phenotype in human breast cancerTony Blick, Honor Hugo, Edwin Widodo, et al.
Cancer Research|August 16, 2014
AXL inhibition sensitizes mesenchymal cancer cells to antimitotic drugsCatherine Wilson, Xiaofen Ye, Thinh Pham, et al.
Molecular Cancer Therapeutics|August 14, 2015
Redesigning a Monospecific Anti-FGFR3 Antibody to Add Selectivity for FGFR2 and Expand Antitumor ActivityYiyuan Yin, Stevan Djakovic, Scot Marsters, et al.
The Biochemical Journal|March 19, 2013
A requirement for wild-type Ras isoforms in mutant KRas-driven signalling and transformationCarolyn Bentley, Stefanie S Jurinka, Noelyn M Kljavin, et al.
Nature|April 17, 2015
A resource for cell line authentication, annotation and quality controlMamie Yu, Suresh K Selvaraj, May M Y Liang-Chu, et al.
Genes & Cancer|July 24, 2014
Amphiregulin and PTEN evoke a multimodal mechanism of acquired resistance to PI3K inhibitionKyle A Edgar, Lisa Crocker, Eric Cheng, et al.
Structure (London, England : 1993)|October 4, 2025
Structural basis for DCAF2 as a novel E3 ligase for PROTAC-mediated targeted protein degradationEvan J McMahon, Alexander G Cioffi, Patrick R Visperas, et al.
Molecular Oncology|June 3, 2008
The morphologies of breast cancer cell lines in three-dimensional assays correlate with their profiles of gene expressionParaic A Kenny, Genee Y Lee, Connie A Myers, et al.
Cancer Research|April 24, 2014
Comparative oncogenomics identifies PSMB4 and SHMT2 as potential cancer driver genesGenee Y Lee, Peter M Haverty, Li Li, et al.
Pageof 5

Showing results (21-30 of 46) with videos related to

Sort By:
Pageof 5
Nature|May 20, 2016
Reproducible pharmacogenomic profiling of cancer cell line panelsPeter M Haverty, Eva Lin, Jenille Tan, et al.
Journal of Mammary Gland Biology and Neoplasia|June 4, 2010
Epithelial mesenchymal transition traits in human breast cancer cell lines parallel the CD44(hi/)CD24 (lo/-) stem cell phenotype in human breast cancerTony Blick, Honor Hugo, Edwin Widodo, et al.
Cancer Research|August 16, 2014
AXL inhibition sensitizes mesenchymal cancer cells to antimitotic drugsCatherine Wilson, Xiaofen Ye, Thinh Pham, et al.
Molecular Cancer Therapeutics|August 14, 2015
Redesigning a Monospecific Anti-FGFR3 Antibody to Add Selectivity for FGFR2 and Expand Antitumor ActivityYiyuan Yin, Stevan Djakovic, Scot Marsters, et al.
The Biochemical Journal|March 19, 2013
A requirement for wild-type Ras isoforms in mutant KRas-driven signalling and transformationCarolyn Bentley, Stefanie S Jurinka, Noelyn M Kljavin, et al.
Nature|April 17, 2015
A resource for cell line authentication, annotation and quality controlMamie Yu, Suresh K Selvaraj, May M Y Liang-Chu, et al.
Genes & Cancer|July 24, 2014
Amphiregulin and PTEN evoke a multimodal mechanism of acquired resistance to PI3K inhibitionKyle A Edgar, Lisa Crocker, Eric Cheng, et al.
Structure (London, England : 1993)|October 4, 2025
Structural basis for DCAF2 as a novel E3 ligase for PROTAC-mediated targeted protein degradationEvan J McMahon, Alexander G Cioffi, Patrick R Visperas, et al.
Molecular Oncology|June 3, 2008
The morphologies of breast cancer cell lines in three-dimensional assays correlate with their profiles of gene expressionParaic A Kenny, Genee Y Lee, Connie A Myers, et al.
Cancer Research|April 24, 2014
Comparative oncogenomics identifies PSMB4 and SHMT2 as potential cancer driver genesGenee Y Lee, Peter M Haverty, Li Li, et al.
Pageof 5